Non-disclosure of drug injection practices as a barrier to HCV testing: results from the PrebupIV community-based research study

Non-disclosure of drug injection practices as a barrier to HCV testing: results from the PrebupIV community-based research study

Abstract Background Hepatitis C virus (HCV) infection prevalence is particularly high in people who inject drugs (PWID), a population that faces many barriers to HCV testing and care. A better understanding of the determinants of access to HCV testing is needed to improve their engagement in the HCV...

Full description

Bibliographic Details
Main Authors: Ilhame Anwar, Cécile Donadille, Camelia Protopopescu, David Michels, Joris Herin, Adélaïde Pladys, Danièle Bader, Patrizia Carrieri, Perrine Roux
Format: Article
Language:English
Published: BMC 2023-07-01
Series:Harm Reduction Journal
Subjects:
HCV testing
PWID
Testing
Disclosure
Stigma
Online Access:https://doi.org/10.1186/s12954-023-00841-7

Internet

https://doi.org/10.1186/s12954-023-00841-7

Similar Items